The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of schedule, the latest in a flurry of changes to longstanding norms and procedures.
FDA Commissioner Marty Makary described the effort as a pilot program during a staff presentation Thursday, saying the first quarterly bonus payments would start going out to employees around August. The Associated Press obtained slides and a recording of the presentation.
